Editorial

Get Permission
Rev Diabet Stud, 2006, 3(1):6-10 DOI 10.1900/RDS.2006.3.6

Costimulation and Pancreatic Autoimmunity: The PD-1/PD-L Conundrum

Deepak Yadav, Nora Sarvetnick

The Scripps Research Institute, Department of Immunology, 10446, North Torrey Pines Road, IMM-23, San Diego, California 92037, USA.
Address correspondence to: Deepak Yadav, e-mail: dyadav@scripps.edu.

Keywords: type 1 diabetes, costimulation, autoimmunity, PD-1, PD-L1, PD-L2

Abstract

T cell activation is a complex process that requires a multitude of interactions between antigen-presenting cells (APC) and T cells. The primary signal is provided via the binding of the antigen (Ag) presented by the major histocompatibility complex (MHC) on an APC and the T cell receptor (TCR). This signal determines the specificity of the immune response but it is not sufficient to mount an effective antigen-specific immune response; co-signals are additionally required for that purpose. These co-signals are costimulatory pathways that can be either positive or negative and consequently determine the nature of the immune response. The B7-1/2/CD28 costimulatory axis is one of the most extensively studied positive signaling pathways, and it has been shown that this signal leads to a robust T cell activation, proliferation and survival. In this article we discuss the recently described PD-1/PD-L1/PD-L2 costimulatory axis, whose role in pancreatic autoimmunity is only just becoming more deeply understood. The blockade or deficiency of PD-1 leads to an exacerbation of diabetes, signifying that the role of PD-1 is to provide negative signals to T cells. On the other hand, the PD-1 ligand, PD-L1, has been shown to provide both positive and negative signals. The prediction of the existence of a non-PD-1 receptor on T cells capable of transmitting positive signals further adds to the complex nature of this costimulatory pathway.

Fulltext: HTML , PDF (231KB)


This article has been cited by other articles:

Tolerance Strategies Employing Antigen-Coupled Apoptotic Cells and Carboxylated PLG Nanoparticles for the Treatment of Type 1 Diabetes

Prasad S, Xu D, Miller SD

Rev Diabet Stud 2012. 9(4):319-327

PD-1 antibody blocks therapeutic effects of T-regulatory cells in Cockroach antigen-induced allergic asthma

McGee HS, Yagita H, Shao Z, Agrawal DK

Am J Respir Cell Mol Biol 2009. Nov 9, epub ahead of print

Changes of B7 family costimulatory molecules and their receptors expression in children with asthma

Zu Y, Li C, Li D, Zheng Y, Li J

J Appl Clin Pediatr 2009. 24(4):271-273

Transplantation of NIT-1 cells expressing PD-L1 for treatment of streptozotocin-induced diabetes

Wen X, Zhu H, Li L, Li Y, Wang M, Liu J, Yang D, Liao W, Shen G

Transplantation 2008. 86(11):1596-1602